PSMA

Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Amgen
BCMA
PSMA
Multiple Myeloma
bispecific antibodies